m5C RNA methylation in cancer: from biological mechanism to clinical perspectives
Cancer remains a significant global health threat, characterized by high morbidity and mortality rates. Despite advancements, numerous challenges persist in cancer treatment, underscoring the urgent need for novel therapeutic strategies. As a burgeoning area of cancer research, increasing evidence highlights the critical role of 5-methylcytosine (m5C ...
Fang Yuan +5 more
openaire +3 more sources
Background RNA m5C methylation has been extensively implicated in the occurrence and development of tumors. As the main methyltransferase, NSUN2 plays a crucial regulatory role across diverse tumor types. However, the precise impact of NSUN2-mediated m5C
Xuran Zhang +16 more
doaj +1 more source
Transcriptome-wide RNA 5-methylcytosine profiles of human iPSCs and iPSC-derived cardiomyocytes
Cardiac regenerative therapy has recently progressed by reprogramming somatic cells into induced pluripotent stem cells (iPSCs) and advanced by large-scale differentiation-derived cardiomyocytes (hiPSC-CMs).
Szu-Ying Chen +6 more
doaj +1 more source
NSUN4-mediated m5C RNA methylation protects retinal cells against excitotoxic injury via the SHH signaling pathway. [PDF]
Li Y, Li D, Geng C, Wei R, Duan Y.
europepmc +1 more source
Emerging roles of RNA N5-methylcytosine modification in reproductive physiology and gynecological diseases. [PDF]
Lv F +10 more
europepmc +1 more source
m5C: Novel Diagnostic and Drug Repurposing Targets for Nonalcoholic Steatohepatitis. [PDF]
Chen S +5 more
europepmc +1 more source
Enhancing plant antiviral responses and productivity through the elimination of m<sup>5</sup>C methyltransferase. [PDF]
Jiang Y +18 more
europepmc +1 more source
Expanding the diversity of DNA base modifications with N 6-methyldeoxyadenosine [PDF]
Kate D. Meyer, Samie R. Jaffrey
core +1 more source
Deep learning model and omics screening highlight angiotensinogen as a 5-methylcytosine (m<sup>5</sup>C) regulated mediator of tumor-microenvironment communication in liver cancer. [PDF]
Pang H, Wang L, Li Y, Zhou Y.
europepmc +1 more source

